3. Tang YD, Zheng XS, Ying TT, et al. Nimodipine-mediated remyelination after facial nerve crush injury in rats. J Clin Neurosci, 2015, 22(10):1661-1668.
[2]
4. Saheb-Al-Zamani M, Yan Y, Farber SJ, et al. Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Exp Neurol, 2013, 247:165-177.
[3]
6. Mirsky R, Woodhoo A, Parkinson DB, et al. Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation. J Peripher Nerv Syst, 2008, 13(2):122-135.
[4]
7. Bronner ME, LeDouarin NM. Development and evolution of the neural crest:an overview. Dev Biol, 2012, 366(1):2-9.
[5]
8. Trainor PA. Specification of neural crest cell formation and migration in mouse embryos. Semin Cell Dev Biol, 2005, 16(6):683-693.
[6]
10. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest, 2009, 119(6):1420-1428.
[7]
11. Dupin E, Sommer L. Neural crest progenitors and stem cells:from early development to adulthood. Dev Biol, 2012, 366(1):83-95.
[8]
12. Finzsch M, Schreiner S, Kichko T, et al. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol, 2010, 189(4):701-712.
[9]
14. Britsch S, Goerich DE, Riethmacher D, et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev, 2001, 15(1):66-78.
[10]
15. Arthur-Farraj P, Wanek K, Hantke J, et al. Mouse schwann cells need both NRG1 and cyclic AMP to myelinate. Glia, 2011, 59(5):720-733.
[11]
17. Nave KA, Salzer JL. Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol, 2006, 16(5):492-500.
[12]
23. Menendez L, Kulik MJ, Page AT, et al. Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc, 2013, 8(1):203-212.
[13]
24. Ma MS, Boddeke E, Copray S. Pluripotent stem cells for Schwann cell engineering. Stem Cell Rev, 2015, 11(2):205-218.
[14]
25. 吴蔚蔚. 噬菌体库筛选猕猴神经干细胞表面标记物. 北京:清华大学, 2010.
[15]
13. Ghislain J, Desmarquet-Trin-Dinh C, Jaegle M, e t al. Characterisation of cis-acting sequences reveals a biphasic, axondependent regulation of Krox20 during Schwann cell development. Development, 2002, 129(1):155-166.
[16]
1. Webber C, Zochodne D. The nerve regenerative microenvironment:early behavior and partnership of axons and Schwann cells. Exp Neurol, 2010, 223(1):51-59.
[17]
2. Fairbairn NG, Meppelink AM, Ng-Glazier J, et al. Augmenting peripheral nerve regeneration using stem cells:A review of current opinion. World J Stem Cells, 2015, 7(1):11-26.
9. Raible DW, Ragland JW. Reiterated Wnt and BMP signals in neural crest development. Semin Cell Dev Biol, 2005, 16(6):673-682.
[20]
16. Adlkofer K, Lai C. Role of neuregulins in glial cell development. Glia, 2000, 29(2):104-111.
[21]
18. Kao SC, Wu H, Xie J, et al. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science, 2009, 323(5914):651-654.
[22]
19. Liu Q, Spusta SC, Mi R, et al. Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells:induction, maintenance, and differentiation into functional schwann cells. Stem Cells Transl Med, 2012, 1(4):266-278.
[23]
20. Lee G, Chamber SM, Tomishima MJ, et al. Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc, 2010, 5(4):688-701.
[24]
21. Wang A, Tang Z, Park IH, et al. Induced pluripotent stem cells for neural tissue engineering. Biomaterials, 2011, 32(22):5023-5032.
[25]
22. Liu Q, Swistowski A, Zeng X. Human neural crest stem cells derived from human pluripotent stem cells. Methods Mol Biol, 2014, 1210:79-90.
